Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech 1 Year Total Returns (Daily) : 28.12% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 28.12% |
| August 20, 2026 | 35.12% |
| August 19, 2026 | 30.14% |
| August 18, 2026 | 29.33% |
| August 17, 2026 | 33.02% |
| August 14, 2026 | 49.49% |
| August 13, 2026 | 54.40% |
| August 12, 2026 | 36.82% |
| August 11, 2026 | 35.94% |
| August 10, 2026 | 51.10% |
| August 07, 2026 | 44.32% |
| August 06, 2026 | 47.34% |
| August 05, 2026 | 46.46% |
| August 04, 2026 | 44.68% |
| August 03, 2026 | 52.49% |
| July 31, 2026 | 69.19% |
| July 30, 2026 | 78.80% |
| July 29, 2026 | 77.25% |
| July 28, 2026 | 71.21% |
| July 27, 2026 | 65.99% |
| July 24, 2026 | 72.16% |
| July 23, 2026 | 77.72% |
| July 22, 2026 | 80.20% |
| July 21, 2026 | 86.77% |
| July 20, 2026 | 70.77% |
| Date | Value |
|---|---|
| July 17, 2026 | 74.09% |
| July 16, 2026 | 73.60% |
| July 15, 2026 | 91.24% |
| July 14, 2026 | 90.31% |
| July 13, 2026 | 74.60% |
| July 10, 2026 | 65.83% |
| July 09, 2026 | 65.33% |
| July 08, 2026 | 55.44% |
| July 07, 2026 | 56.54% |
| July 06, 2026 | 56.91% |
| July 02, 2026 | 66.12% |
| July 01, 2026 | 69.78% |
| June 30, 2026 | 64.52% |
| June 29, 2026 | 62.09% |
| June 26, 2026 | 49.19% |
| June 25, 2026 | 67.78% |
| June 24, 2026 | 75.42% |
| June 23, 2026 | 84.80% |
| June 22, 2026 | 73.03% |
| June 18, 2026 | 65.19% |
| June 17, 2026 | 67.76% |
| June 16, 2026 | 59.24% |
| June 15, 2026 | 54.59% |
| June 12, 2026 | 41.33% |
| June 11, 2026 | 31.43% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Inovio Pharmaceuticals, Inc. | -38.22% |
| Ironwood Pharmaceuticals, Inc. | 263.6% |
| Kura Oncology, Inc. | 59.81% |
| Spero Therapeutics, Inc. | -34.41% |
| Cue Biopharma, Inc. | -1.49% |